Peapack Gladstone Financial Corp Merck & Co., Inc. Transaction History

Peapack Gladstone Financial Corp

$6.51 Billion
Q2 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 704,840 shares of MRK stock, worth $68.7 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

704,840

Previous 711,347 0.91%

Holding current value

$68.7 Million

Previous $93.9 Million 7.03%

% of portfolio

1.34%

Previous 1.47%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $805,566 - $865,170	-6,507 Reduced 0.91%	704,840 $87.3 Million
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $1.6 Million - $1.87 Million	14,139 Added 2.03%	711,347 $93.9 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $912,639 - $993,172	-9,110 Reduced 1.29%	697,208 $76 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $108,303 - $120,275	-1,052 Reduced 0.15%	706,318 $72.7 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $1.97 Million - $2.14 Million	-18,114 Reduced 2.5%	707,370 $81.6 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $423,495 - $472,534	-4,114 Reduced 0.56%	725,484 $77.4 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1.15 Million - $1.47 Million	-13,140 Reduced 1.77%	729,598 $80.9 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $3.99 Million - $4.49 Million	47,247 Added 6.79%	742,738 $64 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $1.03 Million - $1.17 Million	12,325 Added 1.8%	695,491 $63.4 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $625,570 - $701,224	8,510 Added 1.26%	683,166 $56.1 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $93,458 - $117,068	1,293 Added 0.19%	674,656 $51.7 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $7.96 Million - $8.75 Million	111,043 Added 19.75%	673,363 $50.6 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $1.72 Million - $1.9 Million	24,402 Added 4.54%	562,320 $43.7 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $1.29 Million - $1.51 Million	18,664 Added 3.59%	537,918 $41.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $4.79 Million - $5.32 Million	-66,785 Reduced 11.4%	519,254 $42.5 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $137,066 - $155,365	1,873 Added 0.32%	586,039 $48.6 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $15,633 - $17,788	222 Added 0.04%	584,166 $45.2 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $1.56 Million - $2.16 Million	24,562 Added 4.39%	583,944 $44.9 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $531,190 - $599,386	-6,847 Reduced 1.21%	559,382 $50.9 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $240,488 - $262,141	-3,161 Reduced 0.56%	566,229 $47.7 Million
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $767,890 - $897,082	10,995 Added 1.97%	569,390 $47.7 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $68,397 - $78,010	-983 Reduced 0.18%	558,395 $46.4 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $9.99 Million - $11.6 Million	153,060 Added 37.67%	559,378 $42.7 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $486,095 - $571,619	8,426 Added 2.12%	406,318 $28.8 Million
Q2 2018 Aug 09, 2018	BUY	$50.83 - $59.72 $781,562 - $918,254	15,376 Added 4.02%	397,892 $24.2 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $435,045 - $505,646	-8,537 Reduced 2.18%	382,516 $0
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $426,381 - $509,146	8,260 Added 2.16%	391,053 $0
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $819,326 - $881,610	-13,965 Reduced 3.52%	382,793 $0
Q2 2017 Aug 14, 2017	BUY	N/A	396,758	396,758 $0

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Merck & Co., Inc. Transaction History